Using artificial intelligence, researchers have come up with a new way to design nanoparticles that can more efficiently ...

Researchers say COMET’s architecture may also support other areas of nanotechnology where multi-component formulations are critical.

The FDA has approved over 20 RNA-based therapies, with many more in the pipeline, highlighting the evolving regulatory environment that is facilitating the rapid development of these treatments.

It all started in the lab. Two Boston University doctoral students, Joshua McGee and Jack Kirsch, were creating and testing different types of RNA—strands of ribonucleic acid, built from chains ...

A team of doctors and researchers has used artificial intelligence (AI) to develop what they claim could be a new way to more ...

The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not ...

RNA therapies developer miRecule is partnered with Sanofi on the development of a treatment for facioscapulohumeral muscular dystrophy, or FSHD. MiRecule, winner in the biopharma track of MedCity ...

The approval makes donidalorsen the only treatment in the US for hereditary angioedema that is an RNA-targeted prophylactic.

Smaller-scale mutations in the very same gene are also common and quietly nudge millions of people toward type 2 diabetes. A study published in Cell Metabolism reveals why.

A new comprehensive atlas of cells fills gaps in knowledge on how different cells in the intestine act together to drive ...